Jump to navigation
Donate
Two prophylactic pain management regimens for medical abortion ≤63 days’ gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial
The impacts of contraceptive stock-outs on users, providers, and facilities: A systematic literature review
“It's not a seven-headed beast”: Abortion experience among women that received support from helplines for medication abortion in restrictive settings
Preparing for an increased need for abortion access in India during and after COVID‐19: Challenges and strategies
Misoprostol in the era of COVID-19: A love letter to the original medical abortion pill
Self‑managed medication abortion outcomes: Results from a prospective pilot study
Consequences of gestational age limits for people needing abortion care during the COVID-19 pandemic
Gestational age limits for abortion and cross‐border reproductive care in Europe: A mixed‐methods study
Blog: Transforming abortion access beyond the pandemic: Patient experiences with at-home medical abortion through telemedicine in Australia
At-home telemedicine for medical abortion in Australia: A qualitative study of patient experiences and recommendations
